ABBOTT LABORATORIES A/S: Financial statements 2016
CVR: 31528615
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 133,977,634 and a net result of DKK 3,313,889 compared with DKK 10,467,372 the year before. That is a decrease of 4.7% compared with the year before. The profit margin was 2.5%. Equity in the 2016 report amounted to DKK 53,162,631. The solvency ratio was 68.7%.
- Revenue
- DKK 133,977,634
- Gross Profit
- DKK 38,815,995
- Profit/Loss
- DKK 3,313,889
- Equity
- DKK 53,162,631
- Total Assets
- DKK 77,381,579
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 134 mio. | 38.8 mio. | 3.3 mio. | 53.2 mio. | - |
| 2015 | 140.7 mio. | 43.9 mio. | 10.5 mio. | 49.8 mio. | - |
| 2014 | 149.8 mio. | 51.3 mio. | 15.1 mio. | 39.4 mio. | - |
| 2013 | 173.2 mio. | 39.9 mio. | 3.2 mio. | 24.3 mio. | 41 |
Official annual report
Find more companies like ABBOTT LABORATORIES A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of November 11, 2016, Ole Martin Alfstad Christiansen has joined the board of directors of ABBOTT LABORATORIES A/S.
As of November 11, 2016, Peter Frønsdal Toft has left the board of directors of ABBOTT LABORATORIES A/S.
As of November 11, 2016, Ole Martin Alfstad Christiansen is registered as adm. dir. of ABBOTT LABORATORIES A/S.
As of November 11, 2016, Peter Frønsdal Toft has stepped down as adm. dir. of ABBOTT LABORATORIES A/S.
ABBOTT LABORATORIES A/S has published its annual report for 2015. Revenue came to DKK 140,658,524, and the net result was DKK 10,467,372.
As of March 1, 2016, Peter Frønsdal Toft has joined the board of directors of ABBOTT LABORATORIES A/S.
As of March 1, 2016, Jorun Klokk Holst has left the board of directors of ABBOTT LABORATORIES A/S.
As of March 1, 2016, Peter Frønsdal Toft is registered as adm. dir. of ABBOTT LABORATORIES A/S.
As of March 1, 2016, Jorun Klokk Holst has stepped down as adm. dir. of ABBOTT LABORATORIES A/S.
As of February 26, 2016, Brian B. Yoor has joined the board of directors of ABBOTT LABORATORIES A/S.
About ABBOTT LABORATORIES A/S
ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.